modul 2 bleeding a4
TRANSCRIPT
-
8/20/2019 Modul 2 Bleeding a4
1/20
BLEEDING
PBL GROUP A4
PRESENTS
-
8/20/2019 Modul 2 Bleeding a4
2/20
CASE STUDY
A five years old girl was brought to the
hospital because there were red spots on
her arms , lower extrimities and her body.
She also had anal bleeding but no fever .
6 days prior to this , this child had just
recovered from cold.
-
8/20/2019 Modul 2 Bleeding a4
3/20
KEYWORDS
• 5 years old male toddler
• Red spots in arms, legs and body
• Anal bleeding• No e!er
• Re"o!ered rom "o#g$ and "old %
days ago
-
8/20/2019 Modul 2 Bleeding a4
4/20
IMPORTANT QUESTIONS
& What are the diferential diagnoi!
& What "a#e anal $leeding!
& Bleeding %atho%h&iolog&!& 'ae(otai (e"hani(e!
& What i the "onne"tion $et)een the
$leeding and the "o#gh and "old!& 'o) did the red %ot o""#r!
-
8/20/2019 Modul 2 Bleeding a4
5/20
D'((ERENT'A)D'A*NOS'S
• D'SSE+'NATED 'NTRAASCU)ARCOA*U)AT'ON
• 'D'O-AT.'C T.RO+/OCYTO-EN'C-UR-URA
• .AE+O-.')'A
• ON W'))E/RAND (ACTOR D'SEASE
• .ENOC. SC.O)E'N SYNDRO+E
• ACUTE )EUKAE+'AS
-
8/20/2019 Modul 2 Bleeding a4
6/20
• DIC
0 is a "omple1 syndrome 2$i"$"ompli"ates many serio#s ilnesses"a#ses bot$ $aemorr$age andt$rombosis3
• ITP
0 is a disease "$ara"teri4ed byimm#nologi"al destr#"tion o platelet3
• HAEMOPHILIA
- is an in$erited disorder o "oag#lation"a#sed by "oag#lating a"tor die"ien"y
-
8/20/2019 Modul 2 Bleeding a4
7/20
• V! "#S$AS$
- t$e most "ommon in$erited
bleeding disorder "a#sed bym#tations in t$e gene or W(3
• %$&'(% S(%')$#& S*&"+'$
- a systemi" syndrome in!ol!ingsin, *'T 6oints and idneys3 't is"a#sed by !as"#lar anomalies3
-
8/20/2019 Modul 2 Bleeding a4
8/20
• A(-$ )$-/A$#AS
0 A "lini"al maniestation o iron
de7"ien"y2$i"$ a8e"ts t$e rate o
eryt$ropoiesis
and "a#sing anaemia3
-
8/20/2019 Modul 2 Bleeding a4
9/20
"#( #0 haem V! %SS Ac)
5yrs old ♀ 1 2 1 2 1 2 1 2 1 2 1 2
Red spots 1 1 1 1 1 1
Anal leed!n" 1 1 1 1 1 1
#o $e%er 2 1 2 2 2 1
Cold n &o'"( 2 1 1 2 2 1
*OMPARISON TABLE
-
8/20/2019 Modul 2 Bleeding a4
10/20
#"#'0A%#( %+'3'(*'0$(
0-+0-+A
• A disease C$ara"teri4ed byimm#nologi"al destr#"tion oplatelets3
• Di!ided into a"#te and "$roni"3
• A"#te orm #s#ally seen in"$ild$ood, "$roni" #s#ally inyo#ng 2omen3
-
8/20/2019 Modul 2 Bleeding a4
11/20
• AETIOLOG)
0 idiopat$i"• PATHOGE#E*I*
-ACUTE
liely post !iral "ases 'g* antibodyatta"$es to !iral antigen absorbedonto t$e platelet s#ra"e3
0 C.RON'C
A#to antibodies against plateletmembrane3 -latelets sensitised2it$ a#toantibodies destroyed inspleen and li!er3
-
8/20/2019 Modul 2 Bleeding a4
12/20
• ()#(A) !$A-+$S
0 p#rp#ri" ras$
0 "on6#"ti!al $aemorr$age
0 menorr$agia
0 prone to bleed rom m#"o#smembrane
-
8/20/2019 Modul 2 Bleeding a4
13/20
• #&V$S#4A#'&S
0 blood "o#nt and 7lm
0 platelet "o#nt3
0 in"reased bleeding time0 -T and a-TT normal
0 t#rniett test 9:;
-
8/20/2019 Modul 2 Bleeding a4
14/20
• A&A4$$&
+ prednisolone0 spleene"tomy
0 intermittent imm#noglob#lin
0 "y"lop$osp$amide0 dana4ol
0intereron
-
8/20/2019 Modul 2 Bleeding a4
15/20
D'C
C$ara"teri4ed by intra!as"#lardeposition o 7brin anda""elerated degradation o 7brin
and 7brinogen "a#sed by a"ti!ityo proteases3
-
8/20/2019 Modul 2 Bleeding a4
16/20
• A$#')'4*
+ in,e"tion -%arti"#larl& e%ti"ae(ia
+ (alignan"&
+ o$tetri" e(ergen"&
+ ho".
+ e/ere hae(ol&ti" tran,#ionrea"tion
+ li/er dieae
-
8/20/2019 Modul 2 Bleeding a4
17/20
TR'**ER
T'SSUE (ACTORRE)EASE
CYTOK'NERE)EASE
-)AS+'NO*ENACT'ATOR RE)EASE
T(ro+!n
"enerat!o
n
Platelet
a&t!%at!o
n
t(ro+os!s
$!r!n
T!ss'e
ne&ros!s
leed!n"
$!r!nolys!s
Plas+!n "enerat!on
t(ro+o&ytopen!a
-
8/20/2019 Modul 2 Bleeding a4
18/20
• #&V$S#4A#'&
0 red#"ed platelet "o#nt0 -T and a-TT prolonged
0 t$rombin time prolonged
0 7brinogen le!el red#"ed0 $ig$ (D-
A&A4$$&
+ treat(ent o, #nderl&ingdieae
+ 00P and "r&o%re"i%itatead(in
-
8/20/2019 Modul 2 Bleeding a4
19/20
CONC)US'ON
• (rom t$is "ase st#dy, 2e
0 !ario#s types o bleeding disorders
0 #nderlying "a#ses o t$e disorders
0 in!estigations in bleeeding disorders
0 t$e managements and prognosis o
bleeding disorder patients
-
8/20/2019 Modul 2 Bleeding a4
20/20
T.ANK YOU